CD274 and non-small cell lung carcinoma: In the RNA-seq cohort, the EMT signature was higher in patients showing PD than in those showing a PR among patients with PD-L1-high NSCLC, but there were no differences in the EMT signature according to the therapeutic response to ICIs among patients with PD-L1-low NSCLC (Fig. 5a, b).